Augusto Villanueva
Augusto Villanueva
Verified email at
Cited by
Cited by
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ...
Nature genetics 42 (2), 105-116, 2010
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
SM Wilhelm, L Adnane, P Newell, A Villanueva, JM Llovet, M Lynch
Molecular cancer therapeutics 7 (10), 3129-3140, 2008
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ...
New England Journal of Medicine 359 (19), 1995-2004, 2008
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
K Schulze, S Imbeaud, E Letouzé, LB Alexandrov, J Calderaro, ...
Nature genetics 47 (5), 505-511, 2015
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
Y Hoshida, SMB Nijman, M Kobayashi, JA Chan, JP Brunet, DY Chiang, ...
Cancer research 69 (18), 7385-7392, 2009
Pivotal role of mTOR signaling in hepatocellular carcinoma
A Villanueva, DY Chiang, P Newell, J Peix, S Thung, C Alsinet, V Tovar, ...
Gastroenterology 135 (6), 1972-1983. e11, 2008
Genomics and signaling pathways in hepatocellular carcinoma
A Villanueva, P Newell, DY Chiang, SL Friedman, JM Llovet
Seminars in liver disease 27 (01), 055-076, 2007
Genetic landscape and biomarkers of hepatocellular carcinoma
J Zucman-Rossi, A Villanueva, JC Nault, JM Llovet
Gastroenterology 149 (5), 1226-1239. e4, 2015
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
DY Chiang, A Villanueva, Y Hoshida, J Peix, P Newell, B Minguez, ...
Cancer research 68 (16), 6779-6788, 2008
Targeted therapies for hepatocellular carcinoma
A Villanueva, JM Llovet
Gastroenterology 140 (5), 1410-1426, 2011
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
SA Melo, S Ropero, C Moutinho, LA Aaltonen, H Yamamoto, GA Calin, ...
Nature genetics 41 (3), 365-370, 2009
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
JM Llovet, Y Chen, E Wurmbach, S Roayaie, MI Fiel, M Schwartz, ...
Gastroenterology 131 (6), 1758-1767, 2006
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
JM Llovet, A Villanueva, A Lachenmayer, RS Finn
Nature reviews Clinical oncology 12 (7), 408, 2015
Systematic review: evidence‐based management of hepatocellular carcinoma–an updated analysis of randomized controlled trials
PM Lopez, A Villanueva, JM Llovet
Alimentary pharmacology & therapeutics 23 (11), 1535-1547, 2006
Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study
KK Søgaard, E Horváth-Puhó, H Grønbæk, P Jepsen, H Vilstrup, ...
American Journal of Gastroenterology 104 (1), 96-101, 2009
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
BK Yoo, L Emdad, Z Su, A Villanueva, DY Chiang, ND Mukhopadhyay, ...
The Journal of clinical investigation 119 (3), 465-477, 2009
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
A Villanueva, Y Hoshida, C Battiston, V Tovar, D Sia, C Alsinet, ...
Gastroenterology 140 (5), 1501-1512. e2, 2011
Liver cancer cell of origin, molecular class, and effects on patient prognosis
D Sia, A Villanueva, SL Friedman, JM Llovet
Gastroenterology 152 (4), 745-761, 2017
A DNA methylation fingerprint of 1628 human samples
AF Fernandez, Y Assenov, JI Martin-Subero, B Balint, R Siebert, ...
Genome research 22 (2), 407-419, 2012
The system can't perform the operation now. Try again later.
Articles 1–20